ZA85656B - Asymmetrical alkyl diphenylalkylaminoalkyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid - Google Patents

Asymmetrical alkyl diphenylalkylaminoalkyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid

Info

Publication number
ZA85656B
ZA85656B ZA85656A ZA85656A ZA85656B ZA 85656 B ZA85656 B ZA 85656B ZA 85656 A ZA85656 A ZA 85656A ZA 85656 A ZA85656 A ZA 85656A ZA 85656 B ZA85656 B ZA 85656B
Authority
ZA
South Africa
Prior art keywords
diphenylalkylaminoalkyl
dihydro
pyridine
esters
dimethyl
Prior art date
Application number
ZA85656A
Other languages
English (en)
Inventor
Dante Nardi
Amedeo Leonardi
Gabriele Graziani
Giorgio Bianchi
Original Assignee
Recordati Chem Pharm
Chemical & Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10556581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA85656(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Chem Pharm, Chemical & Pharmaceutical Co filed Critical Recordati Chem Pharm
Publication of ZA85656B publication Critical patent/ZA85656B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
ZA85656A 1984-02-14 1985-01-28 Asymmetrical alkyl diphenylalkylaminoalkyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid ZA85656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848403866A GB8403866D0 (en) 1984-02-14 1984-02-14 Diphenylalkylaminoalkyl esters

Publications (1)

Publication Number Publication Date
ZA85656B true ZA85656B (en) 1985-08-28

Family

ID=10556581

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85656A ZA85656B (en) 1984-02-14 1985-01-28 Asymmetrical alkyl diphenylalkylaminoalkyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid

Country Status (29)

Country Link
US (3) US4705797A (xx)
EP (1) EP0153016B1 (xx)
JP (1) JPS60199874A (xx)
KR (1) KR910005231B1 (xx)
AR (1) AR240804A1 (xx)
AT (1) ATE52772T1 (xx)
AU (1) AU570534B2 (xx)
BR (1) BR1101167A (xx)
CA (1) CA1277666C (xx)
DE (2) DE10199007I2 (xx)
DK (1) DK160985C (xx)
DZ (1) DZ748A1 (xx)
EG (1) EG17772A (xx)
ES (1) ES540385A0 (xx)
FI (1) FI83954C (xx)
GB (1) GB8403866D0 (xx)
GR (1) GR850363B (xx)
HU (1) HU194171B (xx)
IE (1) IE57715B1 (xx)
IL (1) IL74238A (xx)
LU (1) LU90069I2 (xx)
MX (1) MX156874A (xx)
NL (1) NL970025I2 (xx)
NO (2) NO166123C (xx)
NZ (1) NZ210866A (xx)
PH (1) PH20725A (xx)
PT (1) PT79963B (xx)
SG (1) SG48590G (xx)
ZA (1) ZA85656B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
DE3677319D1 (de) * 1985-10-22 1991-03-07 Sanwa Kagaku Kenkyusho Co Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
JPH02149563A (ja) * 1988-11-30 1990-06-08 Nisshin Flour Milling Co Ltd ２−ハロエトキシカルボニル基を含有する１，４−ジヒドロピリジン誘導体の製造法
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5767136A (en) * 1995-05-12 1998-06-16 Recordati, S.A. Chemical And Pharmaceutical Company 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
IT1279529B1 (it) * 1995-05-12 1997-12-16 Recordati Chem Pharm Procedimento di preparazione ed uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
IT1274480B (it) * 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
US5851636A (en) * 1995-12-29 1998-12-22 Lantec Products, Inc. Ceramic packing with channels for thermal and catalytic beds
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011727A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi
MXPA05001958A (es) 2002-08-19 2005-04-28 Pfizer Prod Inc Terapia de combinacion para enfermedades hiperproliferativas.
US20050101640A1 (en) * 2002-10-16 2005-05-12 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
EA009646B1 (ru) 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
WO2005107374A2 (en) * 2004-05-07 2005-11-17 Sun Pharmaceutical Industries Limited A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative
CN101090714A (zh) * 2004-07-26 2007-12-19 康泽里克斯公司 通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
US20060134212A1 (en) * 2004-09-02 2006-06-22 Forest Laboratories, Inc. Lercanidipine immediate release compositions
US20060165789A1 (en) * 2004-09-09 2006-07-27 Forest Laboratories, Inc. Lercanidipine modified release compositions
US20060165788A1 (en) * 2004-09-09 2006-07-27 Wattanaporn Abramowitz Lercanidipine pH dependent pulsatile release compositions
KR100616276B1 (ko) * 2004-09-21 2006-08-28 일동제약주식회사 2,엔-디메틸-엔-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
KR100651212B1 (ko) 2004-10-27 2006-12-01 제일약품주식회사 무정형 레르카니디핀의 제조방법
IL165525A0 (en) * 2004-12-02 2006-01-15 Motivan Ltd Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR100638171B1 (ko) * 2005-03-25 2006-10-26 건일제약 주식회사 2,ｎ-디메틸-ｎ-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법
ES2335026T3 (es) 2005-06-15 2010-03-18 Hetero Drugs Limited Nuevo procedimiento de preparacion de lercanipidina.
WO2007031865A2 (en) 2005-09-16 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
WO2007054969A2 (en) * 2005-09-21 2007-05-18 Torrent Pharmaceuticals Limited Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
AU2006313430B2 (en) 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2007120135A1 (en) * 2006-04-17 2007-10-25 Forest Laboratories, Inc. Lercanidipine immediate release composition
EP1860102B1 (en) * 2006-05-24 2008-11-26 CF Pharma Ltd. Process for Producing Lercanidipine
DK2046745T3 (da) * 2006-08-04 2014-01-20 Recordati Ireland Ltd Fremgangsmåde til fremstilling af amorft lercanidipin-hydrochlorid
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
JP2010514753A (ja) * 2006-12-29 2010-05-06 ドンウ シンテック カンパニー リミテッド レルカニジピン塩酸塩の製造方法
KR100848935B1 (ko) 2007-05-16 2008-07-29 주식회사 대희화학 생체 촉매 효소를 이용한 광학 선택적 가수분해방법
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
WO2012123966A1 (en) 2011-03-04 2012-09-20 Arch Pharmalabs Limited Process for the preparation of 4 -substituted -1, 4-dihydropyridines
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
JPS5762257A (en) * 1980-10-03 1982-04-15 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503424D0 (en) * 1985-02-11 1985-03-13 Ici Plc Heterocyclic derivatives

Also Published As

Publication number Publication date
US4968832A (en) 1990-11-06
PH20725A (en) 1987-03-30
AU570534B2 (en) 1988-03-17
AR240804A2 (es) 1991-02-28
GR850363B (xx) 1986-02-06
FI83954B (fi) 1991-06-14
DK63085D0 (da) 1985-02-12
EP0153016A2 (en) 1985-08-28
US4705797A (en) 1987-11-10
EP0153016B1 (en) 1990-05-16
DE3577703D1 (de) 1990-06-21
EG17772A (en) 1991-08-30
FI83954C (fi) 1991-09-25
SG48590G (en) 1990-08-17
JPS60199874A (ja) 1985-10-09
DE10199007I2 (de) 2003-01-09
ES8602664A1 (es) 1985-11-16
CA1277666C (en) 1990-12-11
DE10199007I1 (de) 2001-04-12
FI850535A0 (fi) 1985-02-08
IE57715B1 (en) 1993-03-10
IE850280L (en) 1985-08-14
JPH0517908B2 (xx) 1993-03-10
HUT37399A (en) 1985-12-28
PT79963B (en) 1986-11-10
PT79963A (en) 1985-03-01
NL970025I2 (nl) 1998-01-05
DK160985C (da) 1991-11-04
ES540385A0 (es) 1985-11-16
KR850005826A (ko) 1985-09-26
DZ748A1 (fr) 2004-09-13
IL74238A (en) 1988-07-31
AU3868985A (en) 1985-09-12
AR240804A1 (es) 1991-02-28
LU90069I2 (fr) 1997-07-23
ATE52772T1 (de) 1990-06-15
NO850521L (no) 1985-08-15
IL74238A0 (en) 1985-05-31
BR1101167A (pt) 2004-08-17
NO2000011I1 (no) 2000-10-17
NO166123B (no) 1991-02-25
DK160985B (da) 1991-05-13
EP0153016A3 (en) 1985-10-02
DK63085A (da) 1985-08-15
HU194171B (en) 1988-01-28
MX156874A (es) 1988-10-08
KR910005231B1 (ko) 1991-07-24
NO166123C (no) 1991-06-05
NL970025I1 (nl) 1997-09-01
FI850535L (fi) 1985-08-15
US4772621A (en) 1988-09-20
NZ210866A (en) 1988-07-28
GB8403866D0 (en) 1984-03-21

Similar Documents

Publication Publication Date Title
ZA85656B (en) Asymmetrical alkyl diphenylalkylaminoalkyl esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid
DE3378532D1 (en) 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives
PL252962A1 (en) Method of obtaining novel derivatives of piperazinylocarboxylic-2 acid
GB8500253D0 (en) Slaicyclic acid esters as perfume
AU3867585A (en) Esters of p-dimethylamino-cinnamic acid
EG17195A (en) Alkyl monoperoxysuiccinic acid bleach compositions and process
EP0208272A3 (en) Method for the preparation of alkyl esters of 3,4-epoxybutyric acid
PL251584A1 (en) Method of obtaining novel derivatives of 1,4-dihydropyridine
PL256013A1 (en) Method of obtaining novel derivatives of 6-hydroxynethylpenicillanic acid
DE3562245D1 (en) Esters of 2-bromo-4-methylimidazole-5-carboxylic acid
PL255090A1 (en) Method of obtaining novel optically active substituted 1,4-dihydropyridines
IL75196A (en) Esters of 1,4-dihydro-2,6-dimethyl-3-alkoxycarbonyl or alkoxyalkoxycarbonyl)-4-(substituted phenyl)-pyridine-5-carboxylic acid
GB2155012B (en) Preparation of 2,3-pyridinedicarboxylic acid from 5-halo-8-hydroxyquinoline
EP0177641A3 (en) Manufacture of butanedicarboxylic acid esters
IE842079L (en) Herbicidal 3,5-dicarboxylic acid esters of 2,6-bis¹(fluor0alkyl) tetrahydropyrans and piperidines
CS600986A2 (en) Method of 4-alkoxy-3-pyrroline-2-on-1-yl-acetic acid's alkyl esters production
GB2162187B (en) New derivatives of 11-deoxo-glycyrrhetinic acid
GB8501543D0 (en) Derivatives of acrylic acid
CS393588A1 (en) Method of 2-/4/2-theonyl/phenyl/-propionic acid production
PL137037B2 (en) Method of manufacture of novel asymmetrical 1:2 type chromocomplex dyes
IE850968L (en) Dihydropyridine-3, 5-dicarboxylic acid esters
PL249597A2 (en) Method of manufacture of novel asymmetrical 1:2 type chromocomplex dye
PL246561A1 (en) Method of obtaining new derivatives of 2,4-di/2'-pyrazinylo/pyrimidino-5-carboxylic acid
IL84720A (en) Preparation of alkyl esters of 16-phenoxy-and 16-substituted phenoxy-prosta-4,5,13-trienoic acid